Comparison 4. Infliximab versus placebo.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 At least 50% decrease in HS Severity Index | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected | |
2 Physician Global Assessment (judged to be clear, excellent, or good clinical response) | 1 | Risk Ratio (M‐H, Fixed, 95% CI) | Totals not selected |